ClinicalTrials.gg
CompletedNCT03301987Updated Dec 12, 2017

Chronic Kidney Disease & Therapeutic Exercise

An interventional study of Therapeutic exercise in Kidney and Exercise, sponsored by Universidad de León. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-12-12.

Sponsored by Universidad de León · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 594 studies in Motor Activity with a site in Spain — 147 open to participants now, 183 under way, 1 of them phase 3. Motor Activity · Spain.

Enrollment
525th of 537
9 · median 80
Started
2017
with 32 others
No phase
513 of 594
125 open now
Registered
115th of 594
by date

Among the 594 studies in Motor Activity with a site in Spain, this one is the 525th largest by enrollment of the 537 interventional ones that give a count, is one of 33 that started in 2017, is one of 513 with no phase, and was the 115th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

147 of the 594 studies in Motor Activity with a site in Spain are open now. Recruiting first, the newest first:

142 more — sign in →

All 147 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 594 studies in Motor Activity with a site in Spain, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the therapeutic exercise effects in patients with chronic kidney disease. An interventional prospective study is carried out. A sample of 9 patients with chronic kidney disease is recruited. The kidney function (creatinine clearance as main outcome) is measured at baseline and 1 month after treatment start.

03

Conditions studied

  • Kidney
  • Exercise

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with chronic kidney disease

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment and non signed consent inform form.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Therapeutic exercise

    Other: Therapeutic exercise

Interventions

  • OtherTherapeutic exercise

    30 minutes per day of therapeutic exercise

06

What researchers measure

Primary outcomes

  1. Kidney function

    Creatinine clearance

    Time frame: Change from Baseline creatinine clearance at 1 month

07

Study locations

1 site
  • Pierre Neyra Bohórquez
    Galdakao, Bizkaia 48960, Spain
08

References and documents

Publications

  • Calvo-Lobo C, Neyra-Bohorquez PP, Seco-Calvo J. Aerobic exercise effects in renal function and quality of life of patients with advanced chronic kidney disease. Rev Assoc Med Bras (1992). 2019 Jun 3;65(5):657-662. doi: 10.1590/1806-9282.65.5.657. PubMed 31166442 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Dec 2017, 1 month.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 1 month is below that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2017
First posted
Oct 4, 2017
StartActual
Oct 14, 2017
Primary completionActual
Dec 5, 2017
CompletionActual
Dec 9, 2017
Last update
Dec 12, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 12, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03301987
Lead sponsor
Universidad de León
Responsible party
César Calvo Lobo (PhD, MSc, PT, Universidad de León) — Principal investigator
First posted
Oct 4, 2017
Start date
Oct 14, 2017
Primary completion
Dec 5, 2017
Completion
Dec 9, 2017
Last update
Dec 12, 2017

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion